BioCryst Pharmaceuticals Stock Forecast
BioCryst Pharmaceuticals stock upgraded from Strong Sell Candidate to Sell Candidate after Friday trading session.
(Updated on Apr 26, 2024)
No changes to the price of BioCryst Pharmaceuticals stock on the last trading day (Friday, 26th Apr 2024). During the last trading day the stock fluctuated 3.40% from a day low at $4.12 to a day high of $4.26. The price has fallen in 9 of the last 10 days and is down by -12.79% for this period.
The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.14 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -21.09% during the next 3 months and, with a 90% probability hold a price between $3.27 and $3.92 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BCRX Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioCryst Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.32 and $4.84. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention over the next couple of days.
Support, Risk & Stop-loss for BioCryst Pharmaceuticals stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.140 between high and low, or 3.40%. For the last week, the stock has had daily average volatility of 4.53%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (BCRX) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect BioCryst Pharmaceuticals to open at $4.18, and during the day (based on 14 day Average True Range), to move between $3.91 and $4.41, which gives a possible trading interval of +/-$0.250 (+/-6.02%) up or down from last closing price. If BioCryst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 12.04% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $5.00, some $0.84 (20.19%) from the current price of $4.16, our system finds the risk reward not very attractive.
Is BioCryst Pharmaceuticals stock A Buy?
BioCryst Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -4.516 Sell Candidate Upgraded
Predicted Opening Price for BioCryst Pharmaceuticals of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $4.18 ( 0.481%) | $4.16 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BCRX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 4.32 | 3.85 % | |
| R2 | 4.27 | 2.56 % | ||
| R1 | 4.23 | 1.77 % | ||
| Current price: | 4.16 | |||
| Support | S1 | 4.13 | -0.80 % | |
| S2 | 4.09 | -1.60 % | ||
| S3 | 4.04 | -2.88 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 5.14 | 23.56 % | |
| R2 | 5.08 | 22.12 % | ||
| R1 | 5.00 | 20.19 % | ||
| Current price | 4.16 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy BioCryst Pharmaceuticals Stock.
